AsPC-1-fluc Orthotopic Model


AsPC-1-fluc is a luminescent pancreatic cancer cell line derived from AsPC-1. It expresses luciferase, enabling non-invasive monitoring of tumor growth and response to treatments using bioluminescence imaging techniques. AsPC-1-fluc serves as a valuable tool for preclinical research in pancreatic cancer, allowing researchers to study tumor behavior, evaluate drug efficacy, and explore therapeutic approaches. This cell line offers a practical platform for investigating pancreatic cancer biology and developing novel treatment strategies.

Model Details

Cancer Type: Pancreatic Cancer
Model Name: AsPC-1-fluc
Mouse Strain: Nu/Nu
Treatment Data Available: N/A

AsPC-1-fluc Growth curves

Growth of AsPC-1-fluc after orthotopic intrapancreatic injection of Nu/Nu mice (n=10)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content